These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 10848822

  • 21. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF, de Vries C, Hohmann C, Veerman H, Pannekoek H.
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Difference in expression of the plasminogen activation system in synovial tissue of patients with rheumatoid arthritis and osteoarthritis.
    Ronday HK, Smits HH, Van Muijen GN, Pruszczynski MS, Dolhain RJ, Van Langelaan EJ, Breedveld FC, Verheijen JH.
    Br J Rheumatol; 1996 May; 35(5):416-23. PubMed ID: 8646430
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Tissue and urokinase plasminogen activators (t-PA, u-PA) and their inhibitor PAI-1 in blood of patients with laryngeal neoplasms].
    Białkowska A, Kotschy M, Betlejewski S, Burduk D.
    Otolaryngol Pol; 1995 May; 49 Suppl 20():84-7. PubMed ID: 9454229
    [Abstract] [Full Text] [Related]

  • 26. Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.
    Ganesh S, Sier CF, Heerding MM, van Krieken JH, Griffioen G, Welvaart K, van de Velde CJ, Verheijen JH, Lamers CB, Verspaget HW.
    Br J Cancer; 1997 May; 75(12):1793-801. PubMed ID: 9192984
    [Abstract] [Full Text] [Related]

  • 27. Evidence for an active fibrinolytic system in normal human bone marrow.
    McWilliam NA, Robbie LA, Barelle CJ, Adey G, Prasad S, Bennett B, Booth NA.
    Br J Haematol; 1996 Apr; 93(1):170-6. PubMed ID: 8611456
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Plasminogen activators and their inhibitors in leukemic cell homogenates.
    Wada H, Kumeda Y, Ogasawara Z, Ohiwa M, Kaneko T, Tamaki S, Ohno T, Kageyama S, Kobayashi T, Deguchi K.
    Am J Hematol; 1993 Feb; 42(2):166-70. PubMed ID: 8438877
    [Abstract] [Full Text] [Related]

  • 32. Production of urokinase-type plasminogen activator (u-PA) and plasminogen activator inhibitor-1 (PAI-1) in human brain tumours.
    Arai Y, Kubota T, Nakagawa T, Kabuto M, Sato K, Kobayashi H.
    Acta Neurochir (Wien); 1998 Feb; 140(4):377-85; discussion 385-6. PubMed ID: 9689330
    [Abstract] [Full Text] [Related]

  • 33. Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease.
    Leiper K, Croll A, Booth NA, Moore NR, Sinclair T, Bennett B.
    J Clin Pathol; 1994 Mar; 47(3):214-7. PubMed ID: 8163691
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation.
    Brommer EJ, Dooijewaard G, Dijkmans BA, Breedveld FC.
    Thromb Haemost; 1992 Aug 03; 68(2):180-4. PubMed ID: 1412164
    [Abstract] [Full Text] [Related]

  • 36. Residual plasminogen activator inhibitor activity after venous stasis as a criterion for hypofibrinolysis: a study in 83 patients with confirmed deep vein thrombosis.
    Nguyen G, Horellou MH, Kruithof EK, Conard J, Samama MM.
    Blood; 1988 Aug 03; 72(2):601-5. PubMed ID: 3135860
    [Abstract] [Full Text] [Related]

  • 37. Imbalance of plasminogen activators and their inhibitors in human colorectal neoplasia. Implications of urokinase in colorectal carcinogenesis.
    Sier CF, Verspaget HW, Griffioen G, Verheijen JH, Quax PH, Dooijewaard G, De Bruin PA, Lamers CB.
    Gastroenterology; 1991 Dec 03; 101(6):1522-8. PubMed ID: 1955118
    [Abstract] [Full Text] [Related]

  • 38. Calcium regulation of tissue plasminogen activator and plasminogen activator inhibitor-1 release from cultured human vascular endothelial cells.
    Yamamoto C, Kaji T, Sakamoto M, Kozuka H, Koizumi F.
    Thromb Res; 1994 Apr 15; 74(2):163-8. PubMed ID: 8029817
    [Abstract] [Full Text] [Related]

  • 39. Fibrinolytic and inflammatory processes in pleural effusions.
    Philip-Joët F, Alessi MC, Philip-Joët C, Aillaud M, Barriere JR, Arnaud A, Juhan-Vague I.
    Eur Respir J; 1995 Aug 15; 8(8):1352-6. PubMed ID: 7489803
    [Abstract] [Full Text] [Related]

  • 40. The plasminogen-activation system in ovarian tumors.
    Pujade-Lauraine E, Lu H, Mirshahi S, Soria J, Soria C, Bernadou A, Kruithof EK, Lijnen HR, Burtin P.
    Int J Cancer; 1993 Aug 19; 55(1):27-31. PubMed ID: 8344749
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.